Cancer Biologics Global Market Report 2024: Predictive Biomarkers and Biosimilars Unveil New Horizons in Cancer Biologics

News provided by

Feb 15, 2024, 06:30 ET

DUBLIN, Feb. 15, 2024 /PRNewswire/ -- The "Cancer biologics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.

The report details the impressive surge in the cancer biologics market size from $106.2 billion in 2023 to an expected $117.03 billion in 2024, marking a CAGR of 10.2%. It further projects an increase to $168.75 billion by 2028 at a CAGR of 9.6%, fueled by the relentless pursuit of novel treatment methodologies and an increasing prevalence of chronic diseases such as cancer.

Chronic diseases, particularly cancer, have a substantial impact on health systems worldwide. The report identifies this as a significant factor contributing to the cancer biologics market's growth. Notable market drivers include advancements in biologic efficacy and safety, new regulatory approvals, and the growing adoption of combination therapies.

Investments in Cancer Research: A Catalyst for Market Growth

With rigorous investments fueling cancer research and development, the market is witnessing a surge in innovative cancer biologics. These advancements promise improved patient outcomes and drive the market forward.

Predictive Biomarkers and Biosimilars: New Horizons in Cancer Biologics

Major market players are focusing on predictive biomarkers and the development of cancer biosimilars, contributing to the diversification and accessibility of cancer treatments. Predictive biomarkers are becoming pivotal in early detection and personalized treatment approaches, while the introduction of biosimilars offers cost-effective alternatives to existing biologics.

Strategic Acquisitions: Shaping the Competitive Landscape

The recent acquisition of a global biosimilars business by Biocon Biologics Ltd., signifies strategic movements within the cancer biologics industry, aimed at enhancing the global presence and improving access to biologic treatments.

Geographic and Category Outlook

North America dominates the market landscape as the largest region, while the Middle East emerges as the fastest-growing market, promising dynamic changes in the global market share.

Within the market, various categories such as monoclonal antibodies, vaccines, and cell and gene therapies are extensively analyzed, offering insights into their applications and the channels of distribution in healthcare facilities.

Highlights from the Cancer Biologics Market Report:

Comprehensive analysis of market size and growth predictions up to 2028.
Insights into key growth drivers, including advances in treatment and increasing chronic disease prevalence.
Evaluation of market trends, focusing on predictive biomarkers and biosimilars.
Assessment of strategic acquisitions and their market impact.
Detailed breakdown of market segments and regional market shares.

Key Markets Covered:

By Type: Monoclonal Antibodies; Vaccines; Cell and Gene Therapy; Other Types
By Application: Non-small Cell Lung Cancer; Prostate Cancer; Breast Cancer; Acute Myeloid Leukemia; Lymphoma; Multiple Myeloma; Ovarian Cancer; Colorectal Cancer; Gastric Cancers; Other Applications
By Distribution Channel: Hospitals; Clinics; Other Distribution Channels

Companies Profiled

AbbVie Inc.
F. Hoffmann-La Roche AG
GlaxoSmithKline plc
Eli Lilly and Company
AmgenInc.
Bristol-Myers Squibb Company
Johnson & Johnson
Merck & Co.Inc.
Novartis AG
Pfizer inc.
Celgene Corporation
Serum Institute of India Pvt. Ltd.
Daiichi Sankyo Company Ltd.
Seagen Inc.
Takeda Pharmaceutical Company Limited
Biogen Inc.
Vertex Pharmaceuticals Incorporated
Incyte Corporation
Karyopharm Therapeutics Inc.
Kyowa Kirin Co Ltd.
Ipsen Biopharmaceuticals Inc.
Bayer AG
Biocon Limited
Genentech Inc.
Gilead Sciences Inc.
Puma Biotechnology
Regeneron Pharmaceuticals Inc.
Stryker Corporation
Terumo Corporation

For more information about this report visit https://www.researchandmarkets.com/r/9fehbg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets